Notes archive.
Max Healthcare posts 10% revenue growth, maps ₹1,400 cr Lucknow greenfield hospital
Q4 operating EBITDA up 8% to ₹682 cr; PAT up 3%. Brownfield capacity expansion underway; Kalinga acquisition completed.
NIIT launches six GenAI programs, expands AI portfolio
New courses add to existing lineup but come with no order value or revenue guidance — a typical product update for a training company.
Happy Forgings confirms FY26 results; key moves already disclosed
Audited numbers match prior board meeting; ₹4 final dividend and solar capacity expansion to 35 MW were flagged earlier.
Navigant Corporate Advisors: revenue down 40%, profit down 46% in FY26
The nano-cap advisory firm's annual earnings confirm a material deterioration, with both top and bottom lines halving.
Max Healthcare revenue up 16% in FY26, unveils ₹1,400 cr Lucknow hospital
Q4 revenue rose 10% YoY, while full-year growth topped 16%. The company also completed the Kalinga Hospital acquisition and announced a major greenfield project.
Happy Forgings' annual results were already known; board adds minor solar capex
Routine board meeting: results pre-disclosed, auditors reappointed. Solar plant capacity raised to 35 MW with ₹50 cr additional outlay — immaterial for a ₹11,742 cr market cap.
Cheviot's revenue jumps 24.6% but profit slips on investment losses
Annual results show strong jute sales driving top line, but fair value losses hit bottom line; dividend maintained at ₹25/share.
Ganga Pharma's FY26 results show modest uptick, no surprises
Revenue rose to ₹282.79 lakhs, net profit to ₹10.15 lakhs; clean audit opinion keeps the filing routine for the nano-cap.
D.P. Abhushan's FY26 PAT jumps 88% to ₹212 cr
Revenue crosses ₹4,070 cr, EBITDA up 77% with 234 bps margin expansion; Q4 even stronger.
Oil Country Tubular's losses widen to ₹61.48 cr, revenue slides 43%
FY26 results confirm ongoing distress with no turnaround trigger in sight.
Duroply profit sinks 62% in FY26 despite revenue growth
Nano-cap plywood maker posts Q4 net loss of ₹2.45 cr; one-time labour costs and deferred tax hit earnings.
Windlas Biotech meets FY26 estimates; dividend raised to ₹6.30
Revenue grew 19% to ₹9,041 mn, net profit rose 9% to ₹664 mn. Results were widely anticipated with no material surprises.
Max Healthcare to build ₹1,400 cr hospital in Lucknow
The board approved a 712-bed super specialty facility alongside strong FY26 numbers: revenue up 19%, profit up 34%.
Honasa posts record Q4 revenue, doubles profit, declares maiden dividend
Third consecutive quarter of 20%+ growth; ₹3 per share dividend signals management confidence in cash flows.
Garnet Construction moves to fill MD post after promoter's death
Board to consider Arunkumar Kedia as MD, a critical step to resolve leadership vacuum and restore governance clarity.
Happy Forgings posts 30.7% PAT jump; ₹4 dividend as guided
Audited FY26 results confirm earlier board meeting disclosure. Revenue up 9.8%, PAT up 30.7% — no surprises.
GMM Pfaudler's order backlog jumps 34% to ₹2,194 cr; results in line
Steady revenue and EBITDA growth, but the real news is a growing order book. Core numbers had already been disclosed.
DCM Shriram International files audited results; stamp duty loss already flagged
Procedural filing with unmodified audit opinion and standard dividend recommendation; no new information for the market.
Duroply swings to Q4 loss of ₹2.45 cr, FY profit down 62%
Revenue rose 8.3% to ₹402.67 cr, but deferred tax and exceptional items wiped out profits.
Woodsvilla Ltd full-year profit halves to ₹9.28 lakh
The nano-cap hospitality company reported a Q4 loss of ₹1.81 lakh, reversing a profit in the prior quarter. Auditor gives unmodified opinion.
Ganga Pharma FY26 revenue inches up 7% to ₹282.79 lakhs
Net profit jumps 28% to ₹10.15 lakhs; auditor issues clean opinion. Routine filing for the nano-cap.
Akshar Spintex FY26 loss widens to ₹738.94 lakhs, auditor flags stock verification
Annual net loss rises from ₹444.81 lakhs; Q4 loss narrows to ₹38.97 lakhs from ₹379.50 lakhs in Q3.
Honasa PAT jumps 177% as board declares maiden dividend
FY26 revenue up 14% to ₹2,305.4 crore; Q4 PAT rises 162% to ₹64.5 crore; board recommends ₹3 per share dividend.
Metro Brands cuts e-com mix target, stretches Fila turnaround
Q4 FY26 concall reveals downward revision of online sales guidance and slower ramp for Fila, while BIS constraints linger.
Oil Country Tubular's FY26 loss doubles to ₹61 cr as revenue drops 43%
Audited annual results confirm no turnaround; routine governance changes fail to alter the bleak narrative.